DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
05/03/2023* -- Results Q1 2023 -- 2.63 --
05/03/2023* 08:00 EST Earnings Call Q1 2023 -- -- --
02/15/2023 -- Results Q4 2022 3.84 3.74 2.57%
02/15/2023 08:00 EST Earnings Call Q4 2022 -- -- --
11/01/2022 -- Results Q3 2022 2.64 2.58 2.38%
11/01/2022 08:00 EST Earnings Call Q3 2022 -- -- --
08/02/2022 -- Results Q2 2022 2.75 2.67 3.09%
08/02/2022 08:00 EST Earnings Call Q2 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 05/03/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 02/15/2023
Beat/Miss Upgrade
Return Since -8.39%
Last FQE 12/31/2022
Next FQE 03/31/2023

Profile

Edit
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2021, Waters generated 60% from pharmaceutical customers, 30% from industrial clients, and 10% from academic/government institutions.
URL https://www.waters.com
Investor Relations URL https://www.waters.com/waters/en_US/Investors/nav.htm?cid=134614445&locale=en_US
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release May. 03, 2023 (est.)
Last Earnings Release Feb. 15, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 26, 1996

Dividends

Dividend Per Share (TTM) 0.00
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date Nov. 26, 1996
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
-0.14%
43.75%
-2.35%
23.85%
5.89%
50.59%
-8.06%
-9.91%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
4.67%
-33.29%
70.64%
37.27%
10.61%
11.53%
2.82%
-46.85%
9.60%
23.42%
48.01%
-8.71%
40.26%
43.67%
48.92%
-14.83%
3.79%
--
--
--
--
54.43%
18.78%
-38.13%
7.54%
-88.50%
-99.97%
-99.39%
-89.16%
-15.67%
-56.75%
-53.55%
26.39%
As of March 21, 2023.

Profile

Edit
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2021, Waters generated 60% from pharmaceutical customers, 30% from industrial clients, and 10% from academic/government institutions.
URL https://www.waters.com
Investor Relations URL https://www.waters.com/waters/en_US/Investors/nav.htm?cid=134614445&locale=en_US
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release May. 03, 2023 (est.)
Last Earnings Release Feb. 15, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 26, 1996

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
PHO 68.79M USD 3.99%
PIO 9.947M USD 3.69%
MAW108 133.79M USD 3.03%
MMF1262 35.82M USD 2.99%
CIPMX 135.32M USD 2.55%
PXEAX 57.73M USD 2.40%
NUMG 7.440M USD 2.15%
ATL774 49.01M USD 2.04%
IBB 143.08M USD 1.80%
IHI 95.07M USD 1.65%
BMEZ 30.35M USD 1.53%
AULNX 155.87M USD 1.06%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter WAT Tweets